Monday, August 22, 2022

Why Antibiotics Don't Work - Implications for Clinical Trial Design

›
  I want to discuss the idea of superiority trials for antibiotics and some of the issues that many experienced researchers fail to consider...
Tuesday, April 12, 2022

ASM Microbe - Antimicrobial Agents and Resistance

›
 Guest Blogger Krisztina M. Papp-Wallace   Introducing the ASM Microbe 2022 Antimicrobial Agents and Resistance Program   Dear AAR community...
Monday, March 28, 2022

Pull Incentives for Antibiotic R&D and Private Investment

›
  John Rex (thank you) just sent out an email highlighting a   paper   emanating from the Milliken Institute on how private investment could...
1 comment:
Monday, February 14, 2022

The Future of Antibiotics

›
 Spoiler alert – get out the anti-depressants.   Before I get to the issue at hand, I need to share with you my recent experience posting bl...
Monday, February 7, 2022

Entasis, Antibiotics and the Dodo

›
  And again! Entasis Therapeutics has been  struggling in the public marketplace. There is certainly a risk that it will be going the way of...
3 comments:
Monday, January 31, 2022

To have functioning public health in the US, we must first have national healthcare.

›
  A recent report by the US Government Accountability Office (GAO) highlights risks associated with the response to pandemics at the US Depa...
Monday, December 13, 2021

Covid - Thank you to industry - Please do the same for AMR.

›
  To all those who are skeptical because they worry that a government sponsored investment in the broken antibiotic marketplace is a give-aw...